Menu

AAAS Fellowship to Chemist Repealed

Technician’s death in Patrick Harran’s lab prompted the American Association for the Advancement of Science to yank Harran’s title as a fellow.

Dec 23, 2015
Kerry Grens

WIKIMEDIA, BRENT - UCLAThe American Association for the Advancement of Science (AAAS) had elected Patrick Harran, a biochemist at the University of California, Los Angeles (UCLA), to join its prestigious club of fellows in 2015. But upon further review—specifically, of the death of a technician in a 2008 fire in Harran’s lab—AAAS rescinded the nomination.

“On December 18, the AAAS Council approved the Chemistry Section steering group’s request to conduct a complete re-evaluation of Dr. Harran’s nomination after it became apparent that an initial review of nomination materials had not included all relevant information,” AAAS announced in a statement this week (December 22).

Harran’s selection to become a AAAS fellow was met with criticism. Family members of Sheharbano “Sheri” Sangji, who was killed in the lab fire, said in a letter to AAAS, “no principal investigator who runs their laboratory in a criminally negligent manner as Patrick Harran has should be bestowed with any awards. We respectfully request that you refuse to honor the unsafe science conducted by an unethical scientist.”

Harran paid a $10,000 fine and served 800 hours of community service after he was charged with health and safety code violations.

UCLA released a statement expressing disappointment in AAAS’s move. “Although all concerned lament the tragic laboratory accident that occurred in 2008, Professor Harran’s work has important implications for cancer research and deserves recognition.” 

Naveen Sangji, Sangji’s sibling, said in a statement to Chemistry World: “In rescinding UCLA professor Patrick Harran’s nomination, the AAAS leadership has taken a stance in support of laboratory safety.”

The AAAS fellows subcommittee said it is reconsidering its process for nominating fellows.

Update (December 24): Prompted by Harran's nomination, the American Chemical Society (ACS) was inspired to consider adding safety criteria to its rules for nominating society fellows, reported Chemical & Engineering News (C&EN, which is published by ACS). “At an ACS Board of Directors meeting on Dec. 14, current President Diane Grob Schmidt requested that the board review and reinforce its commitment to safety through its national awards and fellows program, as well as by adding safety to the society’s core values and strengthening references to safety in the Chemical Professional's Code of Conduct,”according to C&EN.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!